What Happened
A registered nurse at a hospital in the Jackson, Mississippi metro area was arrested and charged with embezzlement in May 2017 after investigators alleged he diverted the Schedule II opioids Dilaudid (hydromorphone) and morphine from the hospital's supply.
The arrest followed an investigation by the Mississippi Bureau of Narcotics' Statewide Pharmaceutical Diversion Unit, working with the DEA. Officials described the case as one of several arrests announced around the same time targeting diversion of pharmaceuticals by licensed medical professionals in the state. The nurse surrendered his nursing license as a result of the charge.
What Went Wrong
- Public reporting does not specify how the diversion was first detected, indicating the case surfaced through a law-enforcement investigation rather than an internal hospital control catching the loss in real time.
- A licensed nurse was able to access and remove Schedule II opioids from hospital supply without the loss being caught before an external agency investigation began.
How It Could Have Been Prevented
- Reconcile Schedule II dispensing records against automated cabinet withdrawals and patient administration records on a routine cycle.
- Require prompt internal reporting of any unexplained controlled-substance discrepancy to the hospital's diversion-prevention program and to DEA, rather than relying on outside investigators to surface the loss.
- Screen staff with controlled-substance access against state prescription monitoring and licensure-board records on an ongoing basis.
Related Guidance
- Hospital Diversion Prevention Checklist — Self-assessment covering controlled-substance accountability.
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
- Diversion Case Registry — More documented cases of hospital controlled-substance theft.
- Employee Screening & Fitness for Duty — DEA screening requirements for staff with controlled substance access.